Aytu Biopharma Inc
AYTU2.620USD
+0.220+9.17%
Market hours （ET）Quotes delayed by 15 min
16.17MMarket Cap
9.86P/E TTM
More Details of Aytu Biopharma Inc Company
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Company Info
Ticker SymbolAYTU
Company nameAytu Biopharma Inc
IPO dateOct 20, 2017
CEOMr. Joshua R. (Josh) Disbrow
Number of employees99
Security typeOrdinary Share
Fiscal year-endOct 20
Address7900 E. Union Avenue
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80237
Phone17204376580
Websitehttps://aytubio.com/
Ticker SymbolAYTU
IPO dateOct 20, 2017
CEOMr. Joshua R. (Josh) Disbrow
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
29.46K
+130.24%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
23.81K
+1.79%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
16.00K
--
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
11.15K
--
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
9.82K
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
29.46K
+130.24%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
23.81K
+1.79%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
16.00K
--
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
11.15K
--
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
9.82K
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
ADHD portfolio
15.39M
83.40%
Pediatric portfolio
3.06M
16.58%
Other
4.00K
0.02%
By RegionUSD
Name
Revenue
Proportion
United States
18.45M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
ADHD portfolio
15.39M
83.40%
Pediatric portfolio
3.06M
16.58%
Other
4.00K
0.02%
Shareholding Stats
Updated: Sat, Jun 28
Updated: Sat, Jun 28
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management, LLC
6.39%
Lytton (Laurence W)
5.64%
Stonepine Capital Management, LLC
5.17%
Disbrow (Joshua R.)
1.71%
Other
68.99%
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management, LLC
6.39%
Lytton (Laurence W)
5.64%
Stonepine Capital Management, LLC
5.17%
Disbrow (Joshua R.)
1.71%
Other
68.99%
Shareholder Types
Shareholders
Proportion
Hedge Fund
14.00%
Investment Advisor/Hedge Fund
12.67%
Individual Investor
8.50%
Investment Advisor
0.65%
Other
64.18%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
67
3.22M
35.83%
+940.81K
2025Q1
66
2.05M
28.89%
-146.84K
2024Q4
71
2.05M
33.28%
-280.21K
2024Q3
75
2.20M
40.58%
-328.29K
2024Q2
78
2.26M
43.50%
-3.54K
2024Q1
82
1.99M
41.33%
-356.06K
2023Q4
85
1.96M
40.81%
-395.45K
2023Q3
91
1.92M
40.24%
-406.76K
2023Q2
100
1.89M
40.00%
+821.00K
2023Q1
134
705.12K
28.77%
-175.85K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Nantahala Capital Management, LLC
1.09M
12.11%
--
--
Jun 06, 2025
Kanen Wealth Management, LLC
573.36K
6.39%
+407.09K
+244.84%
Jun 26, 2025
Lytton (Laurence W)
506.61K
5.64%
+506.61K
--
Jun 09, 2025
Stonepine Capital Management, LLC
463.72K
5.17%
+56.17K
+13.78%
Mar 31, 2025
Disbrow (Joshua R.)
153.26K
1.71%
+66.67K
+76.99%
Jun 09, 2025
Renaissance Technologies LLC
76.82K
0.86%
+1.40K
+1.86%
Mar 31, 2025
Armistice Capital LLC
57.60K
0.64%
-92.40K
-61.60%
Mar 31, 2025
Geode Capital Management, L.L.C.
53.94K
0.6%
+11.21K
+26.23%
Mar 31, 2025
Citadel Advisors LLC
30.49K
0.34%
+19.43K
+175.66%
Mar 31, 2025
Disbrow (Jarrett T)
29.46K
0.33%
+16.67K
+130.24%
Jun 09, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Date
Type
Ratio
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
